Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 241 clinical trials
Sequential Neo-adjuvant Chemotherapy Followed by Capecitabine Vs. Conventional Adjuvant Chemotherapy in Breast Cancer

This study evaluates whether sequential neo-adjuvant chemotherapy plus surgery followed by Capecitabine could achieve additional benefits over traditional postoperative chemotherapy. In the

renal function
breast cancer
capecitabine
carcinoma
cancer
  • 0 views
  • 21 Jan, 2021
  • 1 location
Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation

for postoperative circulating tumour DNA with vs. without capecitabine.

  • 0 views
  • 24 Jan, 2021
The Randomised Study of Preoperative Radiotherapy With Consolidating Chemotherapy for Unresectable Rectal Cancer

The addition of Oxaliplatin to conventionally fractionated chemoradiation (FULV or capecitabine) is considered as standard in unresectable rectal cancer by the panel of experts. The

capecitabine
oxaliplatin
chemoradiotherapy
metastasis
  • 1 views
  • 07 Nov, 2020
  • 1 location
Bevacizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

together with combination chemotherapy with or without capecitabine followed by bevacizumab maintenance therapy in treating patients with metastatic colorectal cancer that cannot be removed by

adjuvant therapy
calcium
capecitabine
tumor growth
irinotecan
  • 7 views
  • 07 Nov, 2020
  • 1 location
Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas

This is an open label study to assess the efficacy of capecitabine (CAP) and temozolomide (TMZ) in recurrent pituitary adenomas. There will be a safety run-in of at least three patients to

  • 5 views
  • 28 Jan, 2021
  • 1 location
IMRT-SIB and Capecitabine in Preoperative Rectal Cancer Treatment

fractions concomitant with capecitabine results in an improved pCR rate from 9% (Slovenian trial) to 25%. Secondary objectives are to evaluate pathological down-staging rate, histopathological R0

rectal carcinoma
cancer
renal function
primary tumor
adenocarcinoma of rectum
  • 3 views
  • 08 Nov, 2020
  • 1 location
Combination of Capecitabine and Oxaliplatin in Metastatic Nasopharyngeal Carcinoma

Primary: - To evaluate the efficacy of capecitabine in combination with oxaliplatin (XELOX) in terms of overall response rate (based on RECIST criteria) in patients with

capecitabine
wbc count
karnofsky performance status
carcinoma
metastatic nasopharyngeal carcinoma
  • 15 views
  • 07 Nov, 2020
  • 1 location
Preoperative CRT With Capecitabine Temozolomide in Patients With LARC

This is a prospective biomarker-stratified, randomised phase II study of preoperative CRT with temozolomide plus capecitabine in patients with locally advanced rectal cancer. The primary

  • 15 views
  • 27 Jan, 2021
  • 1 location
Study of the Impact of DPD Activity on the Efficacy of Capecitabine

This study evaluates the Impact of DihydroPyrimidine Dehydrogenase (DPD) activity on the efficacy of Capecitabine in patients with metastatic breast cancer. The DPD phenotype before the

stage iv breast cancer
breast cancer
cancer
  • 0 views
  • 27 Jan, 2021
  • 5 locations
Phase II Study of Maintenance Capecitabine to Treat Resectable Colorectal Cancer

IIIC or R0 resected stage IV. The efficacy and safety of maintenance therapy with capecitabine is still unknown. PURPOSE: This single arm study is exploring surgical resection and adjuvant

adjuvant therapy
adjuvant chemotherapy
xelox regimen
adenocarcinoma of colon
modified folfox6 regimen
  • 16 views
  • 08 Nov, 2020
  • 1 location